Cti Biopharma reported $-19675000 in Pre-Tax Profit for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Applied Genetic Technologies AGTC:US $ -14.28M 0.52M
Cti Biopharma CTIC:US $ -19.68M 2.41M
Cytori Therapeutics CYTX:US $ -2.8M 0.08M
Eli Lilly And LLY:US $ 1988.6M 80.6M
Geron GERN:US $ -29.57M 1.75M
Novartis NVS:US $ 4424M 361M
Novartis NOVN:VX SF 4424M 620M
Sunesis Pharmaceuticals SNSS:US $ -9.17M 70.06M
YTE INCY:US $ 199.6M 31.06M